Notably, radiomics has already been identified as a feasible and effective method to predict tumor immune phenotypes, such as CD8+ T cell infiltration or neutrophil-to-lymphocyte ratios, even PD-1 treatment outcomes [43,44,45,46]. Here, CD8A is linked to neoplasm.